Bio-Rad Laboratories | BIO - Current Liabilities



Bio-Rad Laboratories reported $548.9M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Abbott USD 13.44B 435M Jun/2025
Agilent USD 1.89B 120M Jul/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Bio Techne USD 175.85M 6.64M Jun/2025
Bio-Rad Laboratories USD 548.9M 42.3M Jun/2025
Bruker USD 1.35B 2.5M Jun/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Danaher USD 6.79B 147M Jun/2025
Exact Sciences USD 521.93M 19.47M Jun/2025
General Electric Aerospace USD 36.47B 1.52B Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Illumina USD 1.46B 21M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Laboratory Of America USD 2.72B 652.2M Jun/2025
Merck USD 26.04B 863M Jun/2025
Mettler Toledo International USD 1.11B 42.8M Jun/2025
Myriad Genetics USD 151.1M 13M Mar/2025
Quest Diagnostics USD 2.02B 583M Jun/2025
Repligen USD 152M 25.21M Mar/2025
Revvity USD 671.81M 23.63M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Siemens EUR 43.97B 10.46B Jun/2025
Standard Biotools USD 98.02M 32.13M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Tosoh JPY 337.19B 3.7B Jun/2025
Waters USD 1.02B 55.16M Jun/2025